New drug cocktail aims to tame returning bone marrow cancer
Disease control
Recruiting now
This study tests a combination of four drugs (selinexor, carfilzomib, isatuximab, and dexamethasone) in people whose multiple myeloma has returned or stopped responding to treatment. The goal is to find a safe dose and see how well it controls the cancer. About 62 adults who have…
Phase: PHASE1, PHASE2 • Sponsor: Natalie Callander • Aim: Disease control
Last updated May 17, 2026 04:18 UTC